BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8047805)

  • 1. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
    Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
    Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
    Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
    J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in children.
    Prado D; Liu H; Velasquez T; Cleary TG
    Scand J Infect Dis; 1993; 25(6):713-9. PubMed ID: 8052810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.
    Kabir I; Rahaman MM; Ahmed SM; Akhter SQ; Butler T
    Antimicrob Agents Chemother; 1984 May; 25(5):643-5. PubMed ID: 6329092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
    Ashraf H; Mahalanabis D; Mitra AK; Tzipori S; Fuchs GJ
    Acta Paediatr; 2001 Dec; 90(12):1373-8. PubMed ID: 11853331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections.
    Hovelius B; MĂ„rdh PA; Nygaard-Pedersen L; Wathne B
    Scand J Prim Health Care; 1985 Nov; 3(4):227-32. PubMed ID: 4081404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative controlled clinical trial of pivmecillinam and nalidixic acid in patients with acute simple urinary tract infections.
    Kurokawa K; Fujimura N
    Jpn J Antibiot; 1978 Dec; 31(12):701-11. PubMed ID: 215795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults.
    Salam MA; Seas C; Khan WA; Bennish ML
    Ann Intern Med; 1995 Oct; 123(7):505-8. PubMed ID: 7661494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
    Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
    Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivampicillin/pivmecillinam in the treatment of shigella carriers.
    Ekwall E; Svenungsson B
    Scand J Infect Dis; 1990; 22(5):623-4. PubMed ID: 2259872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
    Islam MR; Alam AN; Hussain MS; Mahalanabis D
    J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.
    Miron D; Torem M; Merom R; Colodner R
    Pediatr Infect Dis J; 2004 Apr; 23(4):367-8. PubMed ID: 15071299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
    Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
    Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.